|
PLK4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.237870E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.359100E-03 |
| Normal-vs-Stage2 |
9.815400E-01 |
| Normal-vs-Stage3 |
3.472300E-02 |
| Normal-vs-Stage4 |
3.387800E-02 |
| Stage1-vs-Stage2 |
9.656900E-03 |
| Stage1-vs-Stage3 |
6.816000E-01 |
| Stage1-vs-Stage4 |
7.678800E-01 |
| Stage2-vs-Stage3 |
3.524000E-02 |
| Stage2-vs-Stage4 |
3.002300E-02 |
| Stage3-vs-Stage4 |
5.846600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.903500E-03 |
| Normal-vs-AfricanAmerican |
4.281600E-02 |
| Normal-vs-Asian |
2.344100E-02 |
| Caucasian-vs-AfricanAmerican |
5.038000E-01 |
| Caucasian-vs-Asian |
6.669600E-01 |
| AfricanAmerican-vs-Asian |
7.726200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.037600E-02 |
| Normal-vs-Female |
1.317660E-02 |
| Male-vs-Female |
8.265000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.756800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.077610E-01 |
| Normal-vs-Age(61-80Yrs) |
1.341000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.522230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.540100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.790400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.293200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.931800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.443000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.953600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.060030E-01 |
| Classical-VS-Follicular |
1.23330001766675E-09 |
| Classical-VS-Other |
2.695600E-01 |
| Classical-VS-Normal |
5.438500E-04 |
| Tall-VS-Follicular |
9.25380000404985E-08 |
| Tall-VS-Other |
6.270500E-02 |
| Tall-VS-Normal |
8.245200E-04 |
| Follicular-VS-Other |
3.381400E-01 |
| Follicular-VS-Normal |
3.420000E-01 |
| Other-VS-Normal |
7.503200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.029400E-01 |
| Normal-vs-N1 |
6.922000E-02 |
| N0-vs-N1 |
2.732600E-01 |
|
|
